CoLucid Pharmaceuticals Inc. (CLCD) Leaped To A New High On Merger News

CoLucid Pharmaceuticals Inc. (CLCD) announced Wednesday morning that it has agreed to be acquired by Eli Lilly & Co. (LLY) for $46.50 per share in cash, or approximately $960 million.

from RTT - Before the Bell http://ift.tt/2iVQ6A7
via IFTTT